Patents by Inventor Norman Nashed

Norman Nashed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6987101
    Abstract: A method for treating premenstrual dysphoric disorder comprises administering a therapeutically effective amount of a gestagen. Optionally, a natural or synthetic estrogen is also administered. In one embodiment, the gestagen and optional estrogen are administered during the luteal phase of the female menstrual cycle, preferably from day 10 to day 28.
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: January 17, 2006
    Assignee: Schering Aktiengesellschaft
    Inventor: Norman Nashed
  • Publication number: 20050282790
    Abstract: This invention describes the use of a therapeutic gestagen (e.g., drospirenone, cyproterone acetate, dienogest) for the production of a pharmaceutical agent for the treatment of premenstrual dysphoric disorder (PMDD), optionally in combination with a natural or synthetic estrogen (e.g., estradiol or ethinylestradiol).
    Type: Application
    Filed: August 16, 2005
    Publication date: December 22, 2005
    Inventor: Norman Nashed